Drug survival of secukinumab for moderate-to-severe plaque psoriasis: reply from authors
British Journal of Dermatology2018Vol. 179(1), pp. 222–223
Citations Over Time
Abstract
Linked Article:Egeberg et al. Br J Dermatol 2018; 178:509–19.
Related Papers
- → Efficacy of secukinumab without the initial weekly loading dose in patients with chronic plaque psoriasis(2019)12 cited
- → Drug survival of secukinumab for moderate-to-severe plaque psoriasis(2018)6 cited
- → Drug survival of secukinumab for moderate-to-severe plaque psoriasis: reply from authors(2018)1 cited
- → Cost-utility of secukinumab in Italian patients with moderate to severe plaque-type psoriasis(2017)
- → Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis(2020)